Tolhurst, G., Heffron, H., Lam, Y
After you eat, your intestinal L-cells release GLP-1, which signals to your brain, pancreas, and digestive tract that food has arrived
Participants in a 12-week human clinical study saw significant improvements: Increased GLP-1 by 140% on average Lost 9 lbs in 8 weeks on average and up to 25 lbs in 12 weeks 100% who lost weight did not lose muscle Lost up to 27% in visceral fat 82% took back control of their relationship with food 95% had decreased sugar cravings Benefits Naturally Increases GLP-1 Supports sustainable weight loss and wellness for results you can see and feel
Ongoing and Future Research While phase 2 results are promising, retatrutides long-term efficacy and safety require further exploration
Clinical studies have demonstrated that these injectable formulations maintain consistent pharmacokinetic profiles regardless of whether they are administered in fasted or fed states
This small but mighty peptide hormone, found in our intestines, is a key player in appetite regulation, glucose metabolism, and digestion
